References
- Althuis MD, Dozier JM, Anderson WF, et al. Global trends in breast cancer incidence and mortality 1973–1997. Int J Nat Cancer Ins 2005; Published online.
- Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: An epidemiological review. J Natl Cancer Inst 2000; 92: 874–897.
- Scholtz CL, Agenbag GM, du Plessis L, et al. Molecular-genetic analysis of South African patients with breast cancer: Identification of novel mutations in the BRCA1 gene. 10th Biennial Congress of the Southern African Society of Human Genetics. Durban, South Africa, May 2003.
- Reeves MD, Yawitch TM, van der Merwe NC, et al. BRCA1 mutations in South African breast and/or ovarian cancer families: Evidence of a novel founder mutation in Afrikaner families. Int J Cancer 2004: 110: 677–682.
- Agenbag GM, Kotze MJ, Apffelstaedt J, Warnich L. Molecular-genetic analysis of the BRCA2 gerie in South African breast cancer patients. 11th Biennial Congress of the Southern African Society of Human Genetics. Muldersdrift, South Africa, March 2005.
- King MC, Marks JH, Mandell JB; et al. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302: 643–646.
- Donaldson MS. Nutrition and cancer: A review of the evidence for an anti-cancer diet. Nutr J 2004; 3: 19 (www.nutritionj.com/content/3/1/19).
- Kotze MJ, Badenhorst H. Chronic disease risk management: Combining genetic testing with medical and nutrition therapy. SA Fam Pract 2005; 47 (4): 40–42.
- Mitrunen K, Kataja V, Eskelinen M, et al. Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk. Pharmacogenetics 2002; 12: 67–72.
- Cheng TC, Chen ST, Huang CS, et al. Breast cancer risk associated with genotype polymorphism of the catechol estrogen- metabolizing genes: A multigenic study on cancer susceptibility. Int J Cancer 2005; 113: 345–353.
- Kocabas NA, Sardas S, Cholerton S, et al. Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility. Cell Biochem Funct 2005; 23:73–76.
- Goodman JE, Lavigne JA, Wu K, et al. COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk. Carcinogenesis 2001; 22: 1661–1665.
- Haase D, Binder C, Bunger J, et al. Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res 2002; 26:249–254.
- Van Kuilenburg ABP, De Abreu RA, Gennip AH. Pharmacogenetic and clinical aspects of dihydropyrimidine dehydrogenase deficiency. Ann Clin Biochem 2003; 40: 41–45.
- Van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. New Engl J Med 2002; 347: 1999–2009.